NASDAQ, MASI - Masimo Corp
We are a global medical technology company that develops, manufactures and
markets non-invasive patient monitoring products that improve patient care. We
were incorporated in California in May 1989 and reincorporated in Delaware in
May 1996. We invented Masimo Signal Extraction Technology, or Masimo SET, which
provides the capabilities of measure-through motion and low perfusion pulse
oximetry to address the primary limitations of conventional pulse oximetry.
Pulse oximetry is the non-invasive measurement of the oxygen saturation level of
arterial blood, or the blood that delivers oxygen to the body?s tissues, and
pulse rate. Our Masimo SET platform has addressed many of the previous
technology limitations and has been referred to by several industry sources as
the gold standard in pulse oximetry. The benefits of Masimo SET have been
validated in over 100 independent clinical and laboratory studies. During fiscal
2007, we generated product revenue of $199. ...
Read SEC Filing on NASDAQ.com »